MoonLake Immunotherapeutics Profile Avatar - Palmy Investing

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phas…
Biotechnology
CH, Zug [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

MoonLake Immunotherapeutics can't present you any valid VpE charts.

Employee Surveys Sample Size: -

There is no qualitative & current survey we can present at the moment.

Talent Acquisition

Permanent Employees Green Cards
Latest 12 Months
Employees
n/A
Wage Range
Min.:$n/A
Avg.:$n/A
Max.:$n/A
High Demand:

MoonLake Immunotherapeutics can't present the data

Other Demand
  • Not available for MoonLake Immunotherapeutics
Temporary Employees H1Bs
Latest 12 Months
Employees
n/A
Wage Range
Min.:$n/A
Avg.:$n/A
Max.:$n/A
High Demand:

MoonLake Immunotherapeutics can't present the data

Other Demand
  • Not available for MoonLake Immunotherapeutics

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of MLTX's Analysis
CIK: 1821586 CUSIP: 61559X104 ISIN: KY61559X1045 LEI: - UEI: -
Secondary Listings
MLTX has no secondary listings inside our databases.